SBIR/STTR Research Award

Fast-Switching, High-Contrast, Electrochromic Sunwear for Persons with Age-Relate

Award identifier c674a781ec5e03502f51baffcd45fec78b936207acc093b97c9033fd27d6d8cbAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$134,082

Program and phase

SBIR · Phase I

Award year

2011

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Ashwin-Ushas Corporation
Proposal award date
Not reported
Contract end date
Not reported
UEI
M37VZM8DT765
Solicitation number
PA10-050
Topic code
NIA

Research abstract

DESCRIPTION (provided by applicant): Age-Related Macular Degeneration (ARMD) afflicts up to 40% of the aging population [1-30]. Studies [6-30] show that gt 70% of the visually impaired population in the US is over 60, and within this, ARMD is the largest cause of impairment. A primary characteristic of ARMD is inability to adapt between light and dark. People with ARMD experience a significant loss in functional vision when going from indoors to outdoors, affecting their ability to function [6-25]. With a solution, the quality of life and well-being of the 40% of older adults who are afflicted with ARMD would drastically improve, allowing them to live more independently and safely. There is currently no medical/surgical treatment for ARMD [1-5]. Current, highly inadequate remedies [6-8] are: (1) Cumbersome, multiple layers of sunglasses, put on/taken off rapidly. (2) Very slow-switching (2 - 5 minutes) photochromic lenses which need UV light for activation. Light-adapting remedies for persons with ARMD wouldalso assist persons with other, age-related diseases, e.g. diabetic retinopathy and corneal dystrophy [8, 25]. In earlier work [31-34], our group carried out an extensive study with age gt 60 veterans having ARMD at the Atlanta VA Center, showing they could benefit highly from fast-darkening (lt 5 s) electrochromic (EC) glasses, when compared to multiple sunglass layers or photochromics. The liquid crystals (LCs) glasses used in this study however had serious problems, e.g. just 24%/3% light/dark range, heavy weight, incompatibility with prescription glasses, high cost. Now in very recent (2009), unrelated work [35-44], in a breakthrough over our prior gen (lt 2008) technology, we have also developed ECs based on conducting polymers (CPs) that have: (1) Typical light/dark contrast of 68.5%/12%, dialable to any value between these extremes. (2) Switching times instantaneous to 5 s. (3) Cyclability gt 10 5 cycles light/dark/light. (4) Excellent optical memory. (5) Thin (lt 20 mils), flexible, durable, solid-state. Affixable to virtually any surface, e.g. prescription/safety glasses. (6) Very low power (15 micro-W/cm2), voltage ( 1.2 VDC). (7) V. inexpensive, est. lt 80/pair. With a small enhancement in the light/dark contrast, use of a battery-powered Controller with photocell input, and extensive ARMD subject testing, these CP-based ECs would be a viable solution to aged ARMD persons. The proposed work will: (1) Fabricate devices with optimized, targeted light/dark contrast of 72%/8%. (2) Fabricate, testinexpensive, battery-powered Controller based on microprocessor, photocell-input, placed on glasses or behind ear, to automatically control darkness/color. (3) Carry out detailed mobility, visual acuity, other tests with ARMD veterans recruited from Atlanta VA Center. (4) Carry out preliminary cost-of-manufacturing survey. The final product would be either thin (lt 5 mil) laminates applied over existing glasses, or safety glasses worn over these or naked eyes, or both, with microprocessor-based, ambient-light-controlled Controller, with a licensed manufacture business model. This firm holds patents for one of the two CPs [39] and is filing others. Pro- posed work is a joint effort between this firm and the Atlanta VA Rehabilitation RandD Ctr. for Aging Vision Loss. PUBLIC HEALTH RELEVANCE: The product proposed will finally provide a remedy for persons with ARMD, who are up to 40% of the aging population and for whom there is no solution at present [1-30], while also assisting persons with other, age-related ocular diseases, e.g. diabetic retinopathy and corneal dystrophy. Other potential applications of such unique, high-performance CP-based electrochromics are in the industrial safety, recreational eyewear, (e.g. ski, sports), automobile windshield and building windows markets, much larger markets which would drastically lower costs for persons with ARMD. Two, specific potential commercial partners have been identified for production.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

41 SBIR/STTR records share this UEI (1993–2022). Reported award amounts total $16,907,893. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.